PrinterPrezz Receives Clearance for 3D Printed Spine Devices Based on UCSF Technology

By Teresa J. Thuruthiyil on October 13, 2020
PrinterPrezz, Inc., a medical polymer and metal 3D printing, nanotechnologies and implant design company, today announced the U.S. Food and Drug Administration (FDA) clearance of the company’s 510(k) for the PrinterPrezz GAIA™ Lumbar Interbody Fusion Device (LIFD) family of spine implants as a...

UC Berkeley’s Jennifer Doudna wins 2020 Nobel Prize in Chemistry

By By Robert Sanders, Media relations on October 07, 2020
University of California, Berkeley, biochemist Jennifer Doudna today won the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier for the co-development of CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine. More

UCSF Health Hub Announces Winners of the Digital Health Awards

By Oiendrilla Das on September 24, 2020
GoodRx, Conversa Health, Ginger& Grand Rounds Among Companies Honored by Expert Judges in Medicine & Venture Capital

Sanofi Acquires Principia Biopharma in $3.6 Billion Deal

August 18, 2020
Sanofi SA will acquire Principia Biopharma Inc. in a $3.68 billion deal that brings Sanofi three clinical-stage BTK inhibitors and simplifies a partnership that began three years ago.

‘AeroNabs’ Promise Powerful, Inhalable Protection Against COVID-19

By Jason Alvarez on August 12, 2020
Led by UCSF graduate student Michael Schoof, a team of researchers engineered a completely synthetic, production-ready molecule that straitjackets the crucial SARS-CoV-2 machinery that allows the virus to infect our cells.

Printerprezz and UCSF Enter Exclusive License Agreement

August 12, 2020
PrinterPrezz announced the exclusive, worldwide license of Spinal Interbody Device technology patent rights from the University of California, San Francisco. More

Exercise May Bolster the Brain

By Gretchen Reynolds on July 20, 2020
Exercise may help change exercisers’ brains in surprising ways, according to a new study of physical activity and brain health. The study, which included both mice and people, found that exercise prompts the liver to pump out a little-known protein, and that chemically upping the levels of that...

Relay Therapeutics Files for $200 Million IPO

June 25, 2020
Founded by UCSF Pharmaceutical Chemist Matt Jacobson, Relay Therapeutics filed for $200 Million IPO on June 25, 2020, and plans to list on the Nasdaq under the ticker RLAY, if accepted.

Sana Biotechnology Announces Completion of Initial Financing

June 23, 2020
Sonja Schrepfer's Sana Biotechnology, announced today the funding of all tranches of its initial financing, raising over $700 million.

Gilead Sciences to Acquire UCSF Startup Pionyr Immunotherapeutics

June 23, 2020
Gilead Sciences set to acquire a 49.9% equity interest in Pionyr and exclusive option for the price of $275 Million. Gilead will also provide funding for Pionyr’s clinical programs and will have the right to acquire the remainder of Pionyr shares for a $315 Million option exercise fee. Pionyr is...